Growth Metrics

Emergent BioSolutions (EBS) Divestments (2023)

Emergent BioSolutions (EBS) has 1 years of Divestments data on record, last reported at $74.9 million in Q2 2023.

  • For Q2 2023, Divestments changed N/A year-over-year to $74.9 million; the TTM value through Dec 2024 reached $74.9 million, changed N/A, while the annual FY2024 figure was $110.2 million, 59.22% down from the prior year.
  • Divestments reached $74.9 million in Q2 2023 per EBS's latest filing.
  • Across five years, Divestments topped out at $74.9 million in Q2 2023 and bottomed at $74.9 million in Q2 2023.